POSA38 Cost-Effectiveness Analysis of for Insulin Degludec (TRESIBA®) vs. Insulin Glargine U300 (TOUJEO®) in Algerian Setting
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.184
https://www.valueinhealthjournal.com/article/S1098-3015(21)01979-3/fulltext
Title :
POSA38 Cost-Effectiveness Analysis of for Insulin Degludec (TRESIBA®) vs. Insulin Glargine U300 (TOUJEO®) in Algerian Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01979-3&doi=10.1016/j.jval.2021.11.184
First page :
Section Title :
Open access? :
No
Section Order :
10958